499 related articles for article (PubMed ID: 10400746)
21. Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
Yokozaki S; Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
J Med Virol; 2011 Oct; 83(10):1727-32. PubMed ID: 21837788
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment.
Berg T; Mas Marques A; Höhne M; Wiedenmann B; Hopf U; Schreier E
Hepatology; 2000 Dec; 32(6):1386-95. PubMed ID: 11093746
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.
Nanbo A; Inoue K; Adachi-Takasawa K; Takada K
EMBO J; 2002 Mar; 21(5):954-65. PubMed ID: 11867523
[TBL] [Abstract][Full Text] [Related]
24. The A150V Polymorphism of Genotype 3 Hepatitis C Virus Polymerase Inhibits Interferon Alfa by Suppressing Protein Kinase R Activation.
Lee WJ; Jones M; Wing PAC; Rajagopal S; Foster GR
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1163-1175. PubMed ID: 33248325
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.
Taylor DR; Shi ST; Romano PR; Barber GN; Lai MM
Science; 1999 Jul; 285(5424):107-10. PubMed ID: 10390359
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB.
Gil J; Alcamí J; Esteban M
Mol Cell Biol; 1999 Jul; 19(7):4653-63. PubMed ID: 10373514
[TBL] [Abstract][Full Text] [Related]
27. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.
Tsai YH; Kuang WF; Lu TY; Kao JH; Lai MY; Liu CJ; Chen PJ; Hwang LH
J Hepatol; 2008 Dec; 49(6):899-907. PubMed ID: 18842320
[TBL] [Abstract][Full Text] [Related]
28. Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells.
Daito T; Watashi K; Sluder A; Ohashi H; Nakajima S; Borroto-Esoda K; Fujita T; Wakita T
Gastroenterology; 2014 Aug; 147(2):463-72. PubMed ID: 24786893
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus controls interferon production through PKR activation.
Arnaud N; Dabo S; Maillard P; Budkowska A; Kalliampakou KI; Mavromara P; Garcin D; Hugon J; Gatignol A; Akazawa D; Wakita T; Meurs EF
PLoS One; 2010 May; 5(5):e10575. PubMed ID: 20485506
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.
Polyak SJ; Paschal DM; McArdle S; Gale MJ; Moradpour D; Gretch DR
Hepatology; 1999 Apr; 29(4):1262-71. PubMed ID: 10094974
[TBL] [Abstract][Full Text] [Related]
31. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.
Chang KS; Cai Z; Zhang C; Sen GC; Williams BR; Luo G
J Virol; 2006 Aug; 80(15):7364-74. PubMed ID: 16840317
[TBL] [Abstract][Full Text] [Related]
32. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA.
Pang Q; Keeble W; Diaz J; Christianson TA; Fagerlie S; Rathbun K; Faulkner GR; O'Dwyer M; Bagby GC
Blood; 2001 Mar; 97(6):1644-52. PubMed ID: 11238103
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus: the role of molecular mimicry in response to interferon treatment.
Uzicanin S; Hu YW; Alsousi H; Pelchat M; Rocheleau L; Nair RC; Brown EG
J Med Virol; 2012 Oct; 84(10):1571-85. PubMed ID: 22930505
[TBL] [Abstract][Full Text] [Related]
34. The non-structural 5A protein of hepatitis C virus.
Pawlotsky JM; Germanidis G
J Viral Hepat; 1999 Sep; 6(5):343-56. PubMed ID: 10607250
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin.
Hung CH; Lee CM; Lu SN; Lee JF; Wang JH; Tung HD; Chen TM; Hu TH; Chen WJ; Changchien CS
J Viral Hepat; 2003 Mar; 10(2):87-94. PubMed ID: 12614464
[TBL] [Abstract][Full Text] [Related]
36. Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner.
Podevin P; Sabile A; Gajardo R; Delhem N; Abadie A; Lozach PY; Beretta L; Bréchot C
Hepatology; 2001 Jun; 33(6):1503-11. PubMed ID: 11391540
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response.
Sarrazin C; Berg T; Lee JH; Rüster B; Kronenberger B; Roth WK; Zeuzem S
J Infect Dis; 2000 Feb; 181(2):432-41. PubMed ID: 10669323
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.
Yang SS; Lai MY; Chen DS; Chen GH; Kao JH
Liver Int; 2003 Dec; 23(6):426-33. PubMed ID: 14986817
[TBL] [Abstract][Full Text] [Related]
39. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
[TBL] [Abstract][Full Text] [Related]
40. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation.
Giménez-Barcons M; Wang C; Chen M; Sánchez-Tapias JM; Sáiz JC; Gale M
J Interferon Cytokine Res; 2005 Mar; 25(3):152-64. PubMed ID: 15767789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
